937-28-0

Upstream product

• 917-64-6 methyl magnesium iodide 
• 874-61-3 4-oxocyclohexanecarboxylic acid 
• 932-00-3 1-methyl-2-oxabicyclo[2.2.2]octane 
• 358759-58-7 ethyl 4-hydroxy-4-methylcyclohexanecarboxylate 

Downstream Products

• 4342-60-3 4-methylcyclohex-3-enecarboxylic acid 
• 859179-02-5 3,4-dibromo-4-methyl-cyclohexanecarboxylic acid 

Relevant academic research and scientific papers

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

PIPERIDINE COMPOUND AND PROCESS FOR PREPARING THE SAME

The present invention is to provide a piperidine compound represented by the formula [I]: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted benzene ring, R1 is hydrogen atom or a substituent for amino group, R2 is hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, Z is oxygen atom or -N(R3)-, R3 is hydrogen atom or an optionally substituted alkyl group, R4a and R4b may be the same or different, and each is hydrogen atom or an optionally substituted alkyl group, or a pharmaceutically acceptable salt thereof, which has an excellent tachykinin receptor antagonistic action.